《盈利預喜》比亞迪(01211.HK)預報首季淨利最多增三倍至9.5億人民幣
比亞迪股份(01211.HK)發盈喜,預計3月止三個月錄得歸屬股東淨利潤介乎6.5-9.5億人民幣,較2021年同期增長174%-300%。
第一季度,新能源汽車行業總體延續了快速增長的勢頭,集團銷量更創下歷史新高,市場佔有率持續攀升,按年實現迅猛增長,帶動盈利大幅改善,且一定程度對沖了上游原材料價格上漲帶來的壓力。然而,手機部件及組裝業務受行業需求疲弱影響,導致產能利用率偏低,業務盈利受壓。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.